Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 6/20 | 0.52 |
| ▸ | PPARD | Q03181 | 5/20 | 0.52 |
| ▸ | PPARA | Q07869 | 5/20 | 0.52 |
| ▸ | TOP1 | P11387 | 3/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | F7 | P08709 | 3/20 | 0.52 |
| ▸ | F3 | P13726 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.52 |
| ▸ | RXRA | P19793 | 1/20 | 0.52 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | FABP4 | P15090 | 3/20 | 0.50 |
| ▸ | BLM | P54132 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | USP2 | O75604 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2209161 | 1.00 | PPARG (0.52) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL3338606 | 0.94 | PPARG (0.57) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL2208064 | 0.94 | PPARG (0.57) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL2208066 | 0.94 | PPARG (0.57) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL2206876 | 0.92 | PPARG (0.60) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL22555583 | 0.92 | PPARG (0.60) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL2208734 | 0.92 | PPARG (0.60) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL2206761 | 0.92 | PPARG (0.60) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL2206758 | 0.92 | PPARG (0.60) | PPARGPPARDPPARATOP1CYP19A1 | |
| SCHEMBL2208737 | 0.92 | PPARG (0.60) | PPARGPPARDPPARATOP1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025229086-A1 | ADHESIVE COSMETIC COMPOUNDS AND USES THEREOF | SKINOSIVE (FR) | 2025-11-06 | — | — | WO | disclosed |
| US-8765809-B2 | Ester derivative and use thereof | AJINOMOTO CO., INC. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-20130053441-A1 | NOVEL ESTER DERIVATIVE AND USE THEREOF | AJINOMOTO CO., INC. (JP) | 2013-02-28 | — | — | US | disclosed |
| US-8212068-B2 | Ester derivative and use thereof | AJINOMOTO CO., INC. (JP) | 2012-07-03 | — | — | US | disclosed |
| US-7981460-B2 | Substituted benzyl ester derivative and use thereof | AJINOMOTO CO., INC. (JP) | 2011-07-19 | — | — | US | disclosed |
| US-7981460-B2 | Substituted benzyl ester derivative and use thereof | AJINOMOTO CO., INC. (JP) | 2011-07-19 | — | — | US | disclosed |
| US-7981460-B2 | Substituted benzyl ester derivative and use thereof | AJINOMOTO CO., INC. (JP) | 2011-07-19 | — | — | US | disclosed |
| US-20090203774-A1 | SUBSTITUTED BENZYL ESTER DERIVATIVE AND USE THEREOF | AJINOMOTO CO., INC. (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090203774-A1 | SUBSTITUTED BENZYL ESTER DERIVATIVE AND USE THEREOF | AJINOMOTO CO., INC. (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090203774-A1 | SUBSTITUTED BENZYL ESTER DERIVATIVE AND USE THEREOF | AJINOMOTO CO., INC. (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090170942-A1 | ESTER DERIVATIVE AND USE THEREOF | AJINOMOTO CO. INC (JP) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053441-A1 | NOVEL ESTER DERIVATIVE AND USE THEREOF | MEP1A, CES2, MEP1B | PPARG 3028/4885PPARD 2917/4885PPARA 3190/4885 |
| US-20090170942-A1 | ESTER DERIVATIVE AND USE THEREOF | MEP1A, CES2, F8 | PPARG 3257/4885PPARD 3272/4885PPARA 3435/4885 |
| US-20090203774-A1 | SUBSTITUTED BENZYL ESTER DERIVATIVE AND USE THEREOF | MEP1B, EBP, MEP1A | PPARG 1794/4885PPARD 2190/4885PPARA 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.